Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Disease (Cancer, Infectious Diseases), By Grade (R&D Grade, GMP Grade), By Application, By Development Phase, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-4-68039-977-1
- Number of Pages: 110
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- Plasmid DNA Manufacturing Grade Outlook (Revenue, USD Million, 2018 - 2030)
- R&D Grade
- GMP Grade
- Plasmid DNA Manufacturing Development Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Plasmid DNA Manufacturing Application Outlook (Revenue, USD Million, 2018 - 2030)
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Plasmid DNA Manufacturing Disease Outlook (Revenue, USD Million, 2018 - 2030)
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Plasmid DNA Manufacturing Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- North America Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- North America Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- North America Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- U.S.
- U.S. Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- U.S. Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- U.S. Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- U.S. Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- U.S. Plasmid DNA Manufacturing Market, By Grade
- Canada
- Canada Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Canada Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Canada Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Canada Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Canada Plasmid DNA Manufacturing Market, By Grade
- North America Plasmid DNA Manufacturing Market, By Grade
- Europe
- Europe Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Europe Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Europe Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Europe Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- UK
- UK Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- UK Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- UK Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- UK Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- UK Plasmid DNA Manufacturing Market, By Grade
- Germany
- Germany Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Germany Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Germany Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Germany Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Germany Plasmid DNA Manufacturing Market, By Grade
- France
- France Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- France Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- France Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- France Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- France Plasmid DNA Manufacturing Market, By Grade
- Italy
- Italy Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Italy Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Italy Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Italy Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Italy Plasmid DNA Manufacturing Market, By Grade
- Spain
- Spain Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Spain Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Spain Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Spain Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Spain Plasmid DNA Manufacturing Market, By Grade
- Denmark
- Denmark Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Denmark Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Denmark Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Denmark Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Denmark Plasmid DNA Manufacturing Market, By Grade
- Sweden
- Sweden Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Sweden Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Sweden Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Sweden Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Sweden Plasmid DNA Manufacturing Market, By Grade
- Norway
- Norway Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Norway Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Norway Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Norway Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Norway Plasmid DNA Manufacturing Market, By Grade
- Europe Plasmid DNA Manufacturing Market, By Grade
- Asia Pacific
- Asia Pacific Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Asia Pacific Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Asia Pacific Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Asia Pacific Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- China
- China Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- China Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- China Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- China Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- China Plasmid DNA Manufacturing Market, By Grade
- Japan
- Japan Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Japan Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Japan Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Japan Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Japan Plasmid DNA Manufacturing Market, By Grade
- India
- India Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- India Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- India Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- India Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- India Plasmid DNA Manufacturing Market, By Grade
- South Korea
- South Korea Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- South Korea Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- South Korea Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- South Korea Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- South Korea Plasmid DNA Manufacturing Market, By Grade
- Australia
- Australia Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Australia Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Australia Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Australia Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Australia Plasmid DNA Manufacturing Market, By Grade
- Thailand
- Thailand Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Thailand Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Thailand Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Thailand Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Thailand Plasmid DNA Manufacturing Market, By Grade
- Asia Pacific Plasmid DNA Manufacturing Market, By Grade
- Latin America
- Latin America Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Latin America Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Latin America Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Latin America Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Brazil
- Brazil Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Brazil Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Brazil Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Brazil Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Brazil Plasmid DNA Manufacturing Market, By Grade
- Mexico
- Mexico Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Mexico Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Mexico Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Mexico Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Mexico Plasmid DNA Manufacturing Market, By Grade
- Argentina
- Argentina Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Argentina Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Argentina Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Argentina Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Argentina Plasmid DNA Manufacturing Market, By Grade
- Latin America Plasmid DNA Manufacturing Market, By Grade
- Middle East & Africa
- Middle East & Africa Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Middle East & Africa Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Middle East & Africa Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Middle East & Africa Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- South Africa
- South Africa Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- South Africa Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- South Africa Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- South Africa Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- South Africa Plasmid DNA Manufacturing Market, By Grade
- Saudi Arabia
- Saudi Arabia Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Saudi Arabia Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Saudi Arabia Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Saudi Arabia Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Saudi Arabia Plasmid DNA Manufacturing Market, By Grade
- UAE
- UAE Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- UAE Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- UAE Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- UAE Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- UAE Plasmid DNA Manufacturing Market, By Grade
- Kuwait
- Kuwait Plasmid DNA Manufacturing Market, By Grade
- R&D Grade
- GMP Grade
- Kuwait Plasmid DNA Manufacturing Market, By Development Phase
- Pre-Clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
- Kuwait Plasmid DNA Manufacturing Market, By Application
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
- Kuwait Plasmid DNA Manufacturing Market, By Disease
- Infectious Disease
- Cancer
- Genetic Disorder
- Others
- Kuwait Plasmid DNA Manufacturing Market, By Grade
- Middle East & Africa Plasmid DNA Manufacturing Market, By Grade
- North America
Plasmid DNA Manufacturing Market Dynamics
Driver: Robust Pipeline for Gene Therapies
Researchers are working to develop gene-based therapies for various diseases. Although the number of patients receiving gene therapies is less, the future of gene therapy holds great promise as it is expected to revolutionize the treatment regime by targeting the genes responsible for disease pathogenesis. Various universities and institutes have a broad portfolio of gene therapy products in the pipeline. For example, the University of Massachusetts Medical School and the University of Utah are conducting several clinical trials that are aimed at developing and introducing new gene therapies in the market. Such developments are expected to boost the demand for various plasmid DNA-based materials required for producing such therapies. Furthermore, considering the future scope and significance of gene therapy in human disease treatment, several companies in the U.S. are adopting various strategic initiatives to broaden their product portfolio.
For instance, in October 2021, Merck KGaA opened its California-based viral vector manufacturing facility to expand its global footprint. This expansion would support industrial manufacturing and large-scale commercialization of viral gene therapy products. Furthermore, with the rising demand for robust disease treatment therapies, research communities have focused their efforts on accelerating their R&D for effective gene therapies that target the root cause of the disease at a genomic level. For instance, in March 2022, the European Medicines Agency approved Carvykti, a new gene therapy, for the treatment of patients with refractory or relapsed multiple myeloma. Such achievements reflect growth potential for the market across the globe.
Driver: Highly Competitive Market and Various Strategies Undertaken by Market Players
The plasmid DNA manufacturing market is highly competitive due to the presence of established and mid-tier companies as well as startups. Various growth strategies adopted by these corporations, such as strategic alliances and collaborations with biopharmaceutical & pharmaceutical companies are propelling market growth. For instance, in October 2022, Ray Therapeutics and Forge Biologics extended their partnership for the inclusion of plasmid DNA manufacturing. As per the agreement, Forge Biologics will offer services for manufacturing research-grade and GMP-Pathway plasmids. Similarly, in January 2020, GenScript and Genopis, Inc. signed a strategic partnership agreement for the promotion & selling of GMP plasmids manufacturing services globally. Such strategic initiatives are increasing the competitive rivalry and are likely to boost market growth.
Furthermore, with an increasing prevalence of chronic diseases, the need for advanced treatment modalities has increased. Thus, key stakeholders, such as research & academic institutions and companies engaged in the development of advanced therapies, are focusing on developing technologically advanced gene delivery systems for effective treatment of various diseases. This is one of the major factors broadening the scope of applications for plasmid DNA manufacturing and fueling market growth.
Restraint: Regulatory, Scientific, And Ethical Challenges Associated with Plasmid
The plasmid DNA manufacturing market is significantly influenced by the utility of plasmids in the production of gene vectors and gene therapies. As gene therapies raise several ethical issues & regulatory concerns, several restrictions have been placed on the use and development of the technology by several governing bodies across the globe. For instance, the U.S. government has restricted the use of federal funds for research on germline gene therapy. Furthermore, regulatory agencies, such as the FDA, have established several guidance documents demonstrating pre-clinical and clinical activities as a key to the regulation & review of gene therapy products. However, the guidelines issued by regulatory bodies of various countries are not aligned or uniform. Guidance from the CDC and the National Institutes of Health are not well-defined. In addition, guidelines from the European Medicines Agency and the U.S. FDA for Good Manufacturing Practice (GMP) regulations about regenerative medicine development are not fully compatible and differ across agencies.
These differences are expected to impede the industrial progress of gene therapies and resultantly impede the growth of plasmid DNA manufacturing. In addition, due to the presence of small size of target patient populations for several products, coupled with their applicability as one-off treatments, the prices for plasmid-DNA-based products need to be set at a level that makes the product economically viable for developers. In the past years, some gene therapies have been withdrawn from the market due to non-financial viability, thereby resulting in uncertainty in the financial sustainability of plasmid DNA-based end products for both developers & payers.
What Does This Report Include?
This section will provide insights into the contents included in this plasmid dna manufacturing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Plasmid dna manufacturing market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Plasmid dna manufacturing market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
